Drugs

, Volume 46, Supplement 1, pp 191–195 | Cite as

Nimesulide in the Treatment of Osteoarthritis

Double-Blind Studies in Comparison with Piroxicam, Ketoprofen and Placebo
  • R. L. Dreiser
  • D. Riebenfeld
Article

Summary

The efficacy and tolerability profiles of nimesulide (a nonsteroidal anti-inflammatory drug) were assessed in 3 comparative double-blind clinical trials that each recruited 60 patients with osteoarthritis of the hip or knee. The duration of each investigation varied with the comparator agent chosen: 2 weeks for placebo; 3 weeks for piroxicam; 2 months for ketoprofen. Nimesulide and ketoprofen were each administered orally as a 100mg dose twice daily, while piroxicam was administered orally as a single daily 20mg dose.

In each study the principal efficacy parameters were the improvement in spontaneous pain, assessed using a visual analogue scale, and the degree of functional impairment evaluated using the severity index of Lequesne; the final judgement of efficacy was made by the physician. In all studies, nimesulide improved these and other efficacy parameters with an activity significantly superior to that of placebo and comparable with that of reference drugs.

Keywords

Osteoarthritis Piroxicam Ketoprofen Nimesulide Mefenamic Acid 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. A1 Arfag A, Davis P. Osteoarthritis 1991. Current drug treatment regimens. Drugs 41: 193–201, 1991PubMedCrossRefGoogle Scholar
  2. Lequesne M, Méry C, Samson M, Gérard P. Indexes of severity for osteoarthritis of the hip and knee. Validation. Value in comparison with other assessments tests. Scandinavian Journal of Rheumatology 16 (Suppl. 65): 85–89, 1987CrossRefGoogle Scholar
  3. Pelletier JP, Martel-Pelletier J. Effects of nimesulide and naproxen on the degradation and metalloprotease synthesis of human osteoarthritic cartilage. Drugs 46 (Suppl. 1): 34–39, 1993PubMedCrossRefGoogle Scholar
  4. Ward A, Brogden RN. Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states. Drugs 36: 732–753, 1988PubMedCrossRefGoogle Scholar

Copyright information

© ADIS International Limited 1993

Authors and Affiliations

  • R. L. Dreiser
    • 1
  • D. Riebenfeld
    • 2
  1. 1.ParisFrance
  2. 2.Department of Products DevelopmentHelsinn Healthcare SAChiassoSwitzerland

Personalised recommendations